Management of Patients with Lower-Risk Myelodysplastic Neoplasms (MDS).
Myelodysplastic neoplasms (MDS) are a heterogenous group of clonal hematologic disorders characterized by morphologic dysplasia, ineffective hematopoiesis, and cytopenia. In the past year, the classification of MDS has been updated in the 5th edition of the World Health Organization (WHO) Classifica...
| Publicado en: | Current Oncology Vol. 30; no. 7; pp. 6177 - 6197 |
|---|---|
| Autores principales: | , , |
| Formato: | Journal Article |
| Publicado: |
MDPI
Jul2023
|
| Acceso en línea: | Ver este registro en EBSCOhost |